Enhanced Liver Fibrosis Test, <scp>FIB</scp> ‐4 and <scp>FibroScan</scp> : Real‐World Prognostic Accuracy for <scp>MASLD</scp> in a Biopsy‐Controlled Cohort
Antonio Liguori(Agostino Gemelli University Polyclinic), Luca Miele(Agostino Gemelli University Polyclinic), Gian Ludovico Rapaccini(Università Cattolica del Sacro Cuore), Giuseppe Marrone(Agostino Gemelli University Polyclinic), Andrea Urbani(Università Cattolica del Sacro Cuore), Tommaso Mazza(Casa Sollievo della Sofferenza), Maurizio Pompili, Giulia Angelini(Università Cattolica del Sacro Cuore), Sara Cardinali(Agostino Gemelli University Polyclinic), Maurizio Sanguinetti(Università Cattolica del Sacro Cuore), Antonio Gasbarrini(Università Cattolica del Sacro Cuore), Francesca D’Ambrosio(Agostino Gemelli University Polyclinic), Consuelo Cefalo(Agostino Gemelli University Polyclinic), Simone Galletti(Agostino Gemelli University Polyclinic), Antonio Grieco(Università Cattolica del Sacro Cuore), Marco Biolato(Agostino Gemelli University Polyclinic), Maria Cristina Giustiniani(Agostino Gemelli University Polyclinic)
Cited by 1
Related Papers
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†
|Hepatology|2009|1.4k
The Liver May Act as a Firewall Mediating Mutualism Between the Host and Its Gut Commensal Microbiota
|Science Translational Medicine|2014|454
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
|Journal of Hepatology|2020|361